Latest AI and machine learning research in geriatrics for healthcare professionals.
Alzheimer’s disease (AD) is characterized by progressive cognitive decline and increased seizure susceptibility; yet both the mechanistic and temporal links between AD and epileptogenesis remain poorly defined. In this study, we conducted a longitudinal analysis of epileptogenesis in relation to AD pathology using hAPP-J20 transgenic mice aged 9 to 27 weeks, encompassing the AD conversion phase. W...
To characterize cell type specific transcriptional changes during human retinal aging and develop machine learning model for cellular age discrimination in a Chinese cohort. Cross-sectional, laboratory-based observational study. Eighteen unfrozen retinas from 12 Chinese donors (9 young, 34-55y; 9 old, 68-92 y). Single-cell RNA sequencing (10x, v3.1) generated 223612 cells, batch-corrected with scV...
Leveraging machine learning on electronic health records offers a promising method for early identification of individuals at risk for dementia and ne...
This study introduces Glucose Level Understanding and Control Optimized for Safety and Efficacy (GLUCOSE), a distributional offline reinforcement lear...
The Social Determinants of Health (SDoH) have long been recognised as significant drivers of health inequalities. Within healthcare settings, large EH...
Chronological age is a cornerstone of medical decision-making but is limited because individuals age at different rates. We recently released an open-...
Poor quality prostate MRI images, especially ADC maps, can lead to missed lesions and unnecessary repeat scans. To address this issue, we aimed to dev...
Foundation models (FMs) show promise in medical AI by learning flexible features from large datasets, potentially surpassing handcrafted radiomics. Ou...
Evaluation of bone marrow morphology by experienced hematologists is key in the diagnosis of myeloid neoplasms, especially to detect subtle signs of d...
Schizophrenia spectrum disorders (SSD) are associated with accelerated brain aging, reflected in an increased brain age gap. This gap serves as a biom...
Rapid developments are occurring in artificial intelligence (AI) and machine learning (ML) applied to neuroimaging. To date, advances in this space ha...
Cognitive decline is a major concern in aging populations. Detecting it before clinical symptoms emerge remains a significant challenge. A precise, re...
Parkinson’s disease (PD) exhibits a variety of symptoms, with approximately 25% of patients experiencing mild cognitive impairment and 45% developing ...
Alzheimer’s disease (AD) presents a critical global health challenge, with current therapies offering limited efficacy and safety in halting disease p...
Given the high prevalence of aging-associated cerebral small vessel disease in the general population, accurate detection of the related white matter ...
Influenza causes about 650,000 deaths worldwide each year, and the high mortality rate of severe cases is closely related to subjective bias in clinic...
Large language models have gained significant public awareness since ChatGPT’s release in 2022. This study describes the perception of chatbot-assiste...
Characterizing the cardinal neuropathologies in Alzheimer disease (AD) can be laborious, time consuming, and susceptible to intra- and inter-observer ...
While large language models (LLMs) are being increasingly deployed for clinical decision support, existing evaluation methods like medical licensing e...
Osteoporosis progresses through stages characterized by declining bone mineral density, vertebral deterioration, and muscle atrophy, with bone-muscle ...